Skip to content
Back to search

NCT07860359Not yet recruiting

Impact of Lung Cancer Screening With Chest Scans Combined With Coaching on Smoking Cessation in Heavy Smokers

Summary

Lung cancer is common and serious, but when detected early, the chances of recovery are significantly better. Tobacco use is the leading cause. To help people break free from smoking, the Fribourg Cantonal Hospital (HFR), the Center for Tobacco Prevention (CIPRET), and the Fribourg Cancer League are joining forces in the STOP-LungCancer study (Smoking Termination Outcomes with Pulmonary Low Dose Computed Tomography for Lung Cancer Screening). What is the goal of this study? The investigators want to determine whether seeing and understanding images of the participants' own lungs helps participants quit smoking for good. Smoking cessation will be verified at 6 months using a breath test (measuring carbon monoxide), followed by a 2-year follow-up. How does participation work? The study is open to 116 residents of the canton of Fribourg aged 50 to 79 who are heavy smokers and motivated to quit. The program includes: 1. Personalized support: 4 smoking cessation coaching sessions organized by CIPRET. 2. Lung computed tomography (CT) scans: 3 exams spaced one year apart. This scan involves no needles or injections. The radiation dose is very low, about 0.6 millisieverts (mSv) per scan, and the associated risk is considered very low. 3. A review of the images with a doctor: During dedicated consultations, a thoracic radiologist reviews the participant's own computed tomography (CT) scans with the participant to explain the condition of the lungs and heart. What are the benefits? Participants receive both tailored support to quit smoking and close monitoring to detect any potential issues at a very early stage.

Inclusion criteria

• Residence in the canton of Fribourg • Willingness to quit smoking • Current smoker: \> or = 20 packs years

Exclusion criteria

• Previous diagnosis of cancer • Major medical problems (Eastern Cooperative Oncology Group, ECOG ≥ 2) • Chest computed tomography (CT) scan in the last 12 months • Hemoptysis or unintentional weight loss \> 7 kilograms (kg) in the last year • Pregnancy • Refusal to be informed of incidental findings of medical importance

Contacts

The trial team's contact details are shown on request.

See the official trial record
Status
Not yet recruiting
Phase
No phase (N/A)
Study type
Interventional
Countries
Switzerland
Sponsor
Hôpital Fribourgeois(Other)
Protocol no.
BASEC-2026-01995
Conditions
Lung Cancer (Diagnosis), Smoking Cessation, Lung Neoplasm
Interventions
Behavioral, Radiation

Treatments studied

  • Image-Based Counseling
  • Smoking Cessation Coaching
  • Low-Dose Chest Computed Tomography (LDCT)

Collaborators

CIPRET Fribourg (Centre d'information pour la prévention du tabagisme)

Locations · 1

  • Fribourg, SwitzerlandFribourg Cantonal Hospital (HFR)Not yet recruiting at this site

In total, worldwide, the only site listed in the registry is planned; recruitment has not opened yet.

Site status per the ClinicalTrials.gov registry (last update posted: October 21, 2026).

This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.

See also

Other versions

These results are indicative and do not replace medical advice — discuss them with your doctor.